Form 4 holding
CHIEF SCIENTIFIC OFF,SVP-R&D
Cara Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 167,247
- Estimated value
- $91,986
- Report date
- 01 Feb 2024
- Price
- $0.5500
- Ownership
- Direct
Frederique Ph.D. Menzaghi - CHIEF SCIENTIFIC OFF,SVP-R&D at Tvardi Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Scientific Off,Svp R&D
- Issuer ticker
- TVRD on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Frederique Ph.D. Menzaghi since 06 Aug 2025
Reported holdings for Frederique Ph.D. Menzaghi in Tvardi Therapeutics, Inc.
Transaction history for Frederique Ph.D. Menzaghi in Tvardi Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.